Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-06-26
2007-06-26
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S012000, C544S013000
Reexamination Certificate
active
10642224
ABSTRACT:
The invention provides novel compounds represented by the general formula compound represented by the formula:whereinthe bond represented by the broken line may be a single, a double bond or absent;and if the bond is absent, then the nitrogen is substituted with a hydrogen and R2;X represents SO2or C═O or CH2;Y represents —CH(R4)—, —N(R4)— or —N(R4)—CH2—, O;and the meaning of R2, R3, R4, R5, R6, R7, and R8are as defined in the applicationThe compounds are useful as positive modulators of the AMPA-receptor.
REFERENCES:
patent: 3261794 (1966-07-01), Gordon et al.
patent: 3275625 (1966-09-01), Müller et al.
patent: 3277086 (1966-10-01), Wei et al.
patent: 3311620 (1967-03-01), Bell et al.
patent: 3351595 (1967-11-01), de Stevens et al.
patent: 3419552 (1968-12-01), Whitehead et al.
patent: 3639342 (1972-02-01), Miyadera et al.
patent: 3969518 (1976-07-01), Novello
patent: 4184039 (1980-01-01), Soldati et al.
patent: 5488049 (1996-01-01), Costa et al.
patent: 5536719 (1996-07-01), Cordi et al.
patent: 6015800 (2000-01-01), Nikam
patent: 6943159 (2005-09-01), Gouliaev et al.
patent: 1125938 (1962-03-01), None
patent: 147316 (1969-04-01), None
patent: 1470316 (1969-04-01), None
patent: 1470316 (1969-04-01), None
patent: 0692484 (1996-01-01), None
patent: 0692484 (1996-01-01), None
patent: 861367 (1961-02-01), None
patent: 863474 (1961-03-01), None
patent: 946864 (1964-01-01), None
patent: 1049322 (1966-11-01), None
patent: 176232 (1981-01-01), None
patent: 176232 (1981-02-01), None
patent: 6025984 (1985-02-01), None
patent: 6025984 (1985-02-01), None
patent: 296964 (1965-05-01), None
patent: WO 932170 (1993-10-01), None
patent: WO 9321170 (1993-10-01), None
patent: WO 9321171 (1993-10-01), None
patent: WO 9321171 (1993-10-01), None
patent: WO 9515759 (1995-06-01), None
patent: WO 9515759 (1995-06-01), None
patent: WO 9638414 (1996-12-01), None
patent: WO 9638414 (1996-12-01), None
patent: WO 9707799 (1997-03-01), None
patent: WO 9707799 (1997-03-01), None
patent: WO 9726884 (1997-07-01), None
patent: WO 9726884 (1997-07-01), None
patent: WO 9736907 (1997-10-01), None
patent: WO 9736907 (1997-10-01), None
patent: WO 9749692 (1997-12-01), None
patent: WO 9749692 (1997-12-01), None
patent: WO 9812185 (1998-03-01), None
patent: WO 9812185 (1998-03-01), None
Imai et al.,Communications, pp. 851-852 (Oct. 1983).
Liang et al.,Journal, 3074475, YHHPAL; Yaoxue Xebao; 10; 1963; 345-354;Chem. Abstr; 59; 13985; 1963.
Foeldi et al.,Journal, 2700364, ACASA2;Acta Chim. Acad. Sci. Hung.; 38; 1963; 147.
E. Marchetti et al.,Journal, 22139, BCFAAI;Boll. Chim. Farm.; IT; 104; 1965.
Alo et al.,J. Chem. Soc. Perkin Trans., No. 5, pp. 805-808 (1986).
Martin et al.,Journal of the Chemica Society, pp. 2451-2458 (1974).
Raffa et al., Cardiovascular Activity of 1,2,4-benzothiadiazine 1,1-dio,Farmaco, Ed. Sci, vol. 29, No. 9, XP002107961, pp. 647-653 (1974).
Ghelardoni et al., Hydrogenolysis of 3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxides VII,Ann. Chim. (Rome), vol. 6 No. 5, XP002107962, pp. 373-384 (1972).
Wales et al.,The Journal of Pharmacology and Experimental Therapeutics, vol. 164, No. 2, pp. 421-432 (1968).
Yale,The Journal of Organic ChemistrY, vol. 33, No. 6, pp. 2382-2385 (Jun. 1968).
Bierbaum et al.,Journal of Medicinal Chemistry, vol. 6, pp. 272-275 (1963).
Kirkien-Rzseszotarski et al.,Journal of Heterocyclic Chemistry, vol. 12, No. 1, pp. 155-159 (Feb. 1975).
Ghelardoni et al.,Ann Chim. (Rome), Hydrogenloysis of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxides V, vol. 58, pp. 1402-1415, XP002107967 (1968).
Loynes et al.,Journal of Medicinal Chemistry, vol. 8, pp. 691-694 (Mar. 9, 1965).
Short et al.,Journal of Organic Chemistry, vol. 26, pp. 3428-3431 (Sep. 1961).
Ghelardoni et al.,Ann. chim. (Rome), vol. 54, pp. 449-461, XP002107969 (1964).
Topliss et al.,Journal of Organic Chemistry, vol. 26, pp. 3842-3850 (Oct. 1961).
Bernabei et al.,Farmaco, Ed. Sci., vol. 31, No. 7, XP002107959, pp. 508-516 (1976).
CAS printout for Werner et al. Chem Abs CA54:12148g.
Werner et al. Dihydrobenzothiadiazine 1,1-dioxides and their diuretic properties, 1960, Chem Abs CA54:12128g.
CAS printout for Orita et al. Chem Abs. 99:169045.
CAS printout for Di et al. Chem Abs. 88:145975.
CAS printout for Abramovitch et al. Chem Abs. 87:117236.
CAS printout for Ghelardoni et al. Chem Abs. 68:12959 and Chem Abs. 67:108649.
Gay, “Bendrofluazide Assay Including Extractive Alkylation for GC,” Methodol. Surv. Biochem., 1978, pp. 133-139 No. 7.
Topliss et al.,Journal of Medicinal Chemistry,vol. 15, No. 4, pp. 400-403 (1972).
Imai et al.,Communications,pp. 851-852 (Oct. 1983).
Liang et al.,Journal,3074475, YHHPAL; Yaoxue Xebao; 10; 1963; 345-354;Chem. Abstr,59; 13985; 1963.
Foeldi et al.,Journal,2700364, ACASA;Acta Chim. Acad. Sci. Hung.;38; 1963; 147.
E. Marchetti et al.,Journal,22139, BCFAAI;Boll. Chim. Farm.;IT; 104; 1965.
Alo et al.,J. Chem. Soc. Perkin Trans.,No. 5, pp. 805-808 (1986).
Martin et al.,Journal of the Chemica Society,pp. 2451-2458 (1974).
Raffa et al.,Cardiovascular Activity of 1, 2, 4-benzothiadiazine—1, 1-dio,Farmaco, Ed. Sci,vol. 29, No. 9, XP002107961, pp. 647-653 (1974).
Ghelardoni et al.,Hydrogenolysis of 3,4-dihydro-1,2,4-benzothiadiazine 1, 1-dioxides—VII,Ann. Chim.(Rome), vol. 6 No. 5, XP002107962, pp. 373-384 (1972).
Wales et al.,The Journal of Pharmacology and Experimental Therapeutics,vol. 164, No. 2, pp. 421-432 (1968).
Yale,The Journal of Organic Chemistry,vol. 33, No. 6, pp. 2382-2385 (Jun. 1968).
Bierbaum et al.,Journal of Medicinal Chemistry,vol. 6, pp. 272-275 (1963).
Kirkien-Rzseszotarski et al.,Journal of Heterocyclic Chemistry,vol. 12, No. 1, pp. 155-159 (Feb. 1975).
Ghelardoni et al.,Ann Chim.(Rome),Hydrogenolysis of 3,4-dihydro-1,2,4-benzothiadiazine-1, 1-dioxides V,vol. 58, pp. 1402-1415, XP002107967 (1968).
Loynes et al.,Journal of Medicinal Chemistry,vol. 8, pp. 691-694 (Mar. 9, 1965).
Short et al.,Journal of Organic Chemistry,vol. 26, pp. 3428-3431 (Sep. 1961).
Ghelardoni et al.,Ann. chim.(Rome), vol. 54, pp. 449-461, XP002107969 (1964).
Topliss et al.,Journal of Organic Chemistry,vol. 26, pp. 3842-3850 (Oct. 1961).
Bemabei et al.,Farmaco, Ed. Sci.,vol. 31, No. 7, XP002107959, pp. 508-516 (1976).
Gouliaev Alex Haaht
Johansen Tina Holm
Larsen Mogens
Mathiesen Claus
Nielsen Elsesbet Ostergaard
Birch & Stewart Kolasch & Birch, LLP
Habte Kahsay
NeuroSearch A/S
LandOfFree
Compounds and their use as positive AMPA receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and their use as positive AMPA receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and their use as positive AMPA receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3850842